Ganglion Cell Complex Analysis as a Potential Indicator of Early Neuronal Loss in Idiopathic Intracranial Hypertension. (2nd January 2019)

• Record Type: Journal Article
• Authors: Athappilly, Geetha; García-Basterra, Ignacio; Machado-Miller, Flavia; Hedges, Thomas R.; Mendoza-Santiesteban, Carlos; Vuong, Laurel
• Is Part Of: Neuro-ophthalmology. Volume 43:Number 1(2019)
• Page Start: 10
• Page End: 17
• Publication Date: 2019-01-02
• Subjects: Papilledema -- ganglion cell analysis -- Idiopathic Intracranial Hypertension (IIH) -- Optical Coherence Tomography (OCT) -- pseudotumor cerebri; Neuroophthalmology -- Periodicals; 617.7
• DOI: 10.1080/01658107.2018.1476558
• Languages: English
• ISSNs: 0165-8107

Abstract

ABSTRACT: Reliable visual field testing is the gold standard in identifying future vision loss in patients with Idiopathic Intracranial hypertension (IIH). However, when field performance is unreliable, GCC analysis may be useful. We evaluated IIH patients over three visits: initial visit, follow-up visit and a third visit, almost 1 year later. We evaluated mean deviation (MD), GCC and RNFL at presentation and the second visit and compared it to the mean deviation (MD) on fields at the third visit. As early as the second visit, GCC loss correlated with visual field results seen at the third visit.